RP11-553 L6.5, ZFY-AS1, RP4-803, and RP1-43E13.2 were also described as modulators of MM disease progression, as a result of their correlation with epigenetic changes connected to MM [119]. Here, ZFY is linked to Miyoshi myopathy.